![Susan D. Wyrick](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Susan D. Wyrick
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
OncoGenex Pharmaceuticals, Inc.
![]() OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA.
2
| Extinct | Pharmaceuticals: Major | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Susan D. Wyrick via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Corixa Corp.
![]() Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Director of Finance/CFO Director of Finance/CFO | |
PHASERX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Polynoma LLC
![]() Polynoma LLC BiotechnologyHealth Technology Part of CK Life Sciences International (Holdings), Inc., Polynoma LLC is an immuno-oncology focused biopharmaceutical company headquartered in San Diego, CA. Polynoma's lead asset is a novel polyvalent antigen vaccine, Seviprotimut-L, for the prevention of recurrence of melanoma. The vaccine has been safely administered in more than 1,000 patients. Polynoma is an immuno-oncology company developing a novel polyvalent antigen therapy for the treatment of melanoma. The company was founded by Paul A. Hopper. | Biotechnology | Director/Board Member Director/Board Member | |
Virginia Mason Health System
![]() Virginia Mason Health System Hospital/Nursing ManagementHealth Services Virginia Mason Health System offers medical services. It is the parent company of a group of affiliated organizations including Virginia Mason Medical Center and the Benaroya Research Institute at Virginia Mason. The firm support the healthcare and research missions of the Virginia Mason Medical Center and Benaroya Research Institute at Virginia Mason. The company was founded in 1920 and is headquartered in Seattle, WA. | Hospital/Nursing Management | Director/Board Member Director/Board Member | |
Virginia Mason Medical Center
![]() Virginia Mason Medical Center Medical/Nursing ServicesHealth Services Virginia Mason Medical Center provides healthcare services. It offers primary and cancer care, diabetes center, digestive disorders, heart care, neurology and neurosurgery, medicine, surgery, urology, and orthopedics and sports. The company was founded by James Tate Mason, John M. Blackford, and Maurice Dwyer in 1920 and is headquartered in Seattle, WA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Emergent Product Development Seattle
![]() Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
Seattle University | College/University | Masters Business Admin Masters Business Admin | |
George Mason University | College/University | Undergraduate Degree Undergraduate Degree | |
ACER THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Universal Cells, Inc.
![]() Universal Cells, Inc. BiotechnologyHealth Technology Universal Cells, Inc. develops, licenses and commercializes stem cell therapies. The company was founded by Claudia Mitchell and David Russell and is headquartered in Seattle, WA. | Biotechnology | Chairman | |
Pacific Biotechnology Consulting Group
![]() Pacific Biotechnology Consulting Group Miscellaneous Commercial ServicesCommercial Services Pacific Biotechnology Consulting Group provides consulting services to biotechnology companies. The private company is based in Seattle. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
HTG MOLECULAR DIAGNOSTICS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
ADAPTIVE BIOTECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member | |
CHINOOK THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 18 |
Sectoraal
Health Technology | 12 |
Health Services | 3 |
Consumer Services | 3 |
Commercial Services | 3 |
Operationeel
Director/Board Member | 17 |
Director of Finance/CFO | 8 |
Independent Dir/Board Member | 5 |
Chief Operating Officer | 4 |
Undergraduate Degree | 2 |
Sterkste connecties
Insiders | |
---|---|
Michelle Griffin | 18 |
Michelle Burris | 11 |
- Beurs
- Insiders
- Susan D. Wyrick
- Bedrijfsconnecties